子宫内人工授精器市场：现况分析与预测（2023-2030）

由于全球不孕症的普遍存在，子宫内人工授精装置市场预计将以约 3.7% 的稳定速度成长。 例如，根据世界卫生组织 (WHO) 的统计，全世界六分之一的人在一生中都会经历不孕的经历。 在预测期内，有几个因素正在推动市场成长，例如寻找有效治疗方法的临床试验数量的增加、医疗保健产业投资的增加。 除此之外，子宫内人工授精设备的加速上市增加了对有效治疗的需求，这也稳步推动了子宫内人工授精设备市场。

依产品类型，市场分为子宫内授精导管和子宫内授精精子清洁器。 由于不孕症患者的增加，子宫腔内人工授精的精子清洁装置市场在2022年占据主导地位。 子宫腔内人工授精 精子清洗是在人工授精过程中准备将精子插入子宫的过程。 这涉及从精液样本中分离健康、活动的精子，并去除潜在的有害物质，如前列腺素、细菌和死精子。 因此，在产品类型中，子宫内人工授精精子清洁细分市场在2022年占据了重要的市场占有率。

根据最终用户，市场分为医院、IVF 诊所等。 在预测期内，由于医院患者数量不断增加，诊所部门预计将在市场中占据主要占有率。 诊所部门在子宫内人工授精 (IUI) 设备市场中发挥重要作用，因为诊所是子宫内人工授精 (IUI) 服务的主要提供者。 此细分市场包括生育诊所、生殖健康中心和提供辅助生殖技术 (ART) 服务的医院。 影响这一领域的主要因素包括子宫内人工授精设备的技术进步、对不孕症治疗的认识不断提高以及对替代怀孕方法的需求不断增长。 此外，监管政策、报销情况和患者偏好等因素也会影响 IUI 设备市场中诊所部门的动态。 因此，在预测期内，诊所类别在最终用户中将表现出更高的复合年增长率。

为了更瞭解市场，市场分为北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、西班牙、义大利、欧洲其他地区）、亚太地区（中国、日本、印度、亚太地区其他地区）和世界其他地区。 由于不孕症患者的快速增加、医疗保健成本的增加以及引入创新进步的举措和投资的增加，北美在 2022 年目前的情况下将主导市场。 例如，美国 Mosie Baby 的家用人工授精套件于 2023 年 12 月获得 FDA 批准。 由于该地区不孕症病例的增加，政府机构启动了提高意识计画。 这样一来，依地区划分，2022年北美将占据很大一部分市场占有率。

市场上营运的主要公司包括 CooperSurgical Fertility Company、Cook Group Incorporated、Vitrolife Scotland AB、Kitazato Corporation、FUJIFILM Irvine Scientific、MEDGYN PRODUCTS, INC.、Rocket Medical plc.、Thomas Medical、Famasys Inc.、Allwin Medical Medical设备等。

目录

第一章市场介绍

• 市场定义
• 主要目标
• 利害关係人
• 限制

第二章研究方法或前提

• 调查过程
• 调查方法
• 受访者简介

第三章市场总结

第 4 章执行摘要

第五章 COVID-19 对子宫内人工授精设备市场的影响

第六章2020-2030年宫内人工授精装置市场收入

第七章依产品类型进行市场分析

• 子宫内人工授精导管
  • 弯曲型
  • 灵活
  • 线性型
• 子宫内人工授精精子清洁装置

第 8 章最终用户市场分析

• 医院
• 诊所
• 其他

第九章区域市场分析

• 北美
  • 美国
  • 加拿大
  • 其他北美地区
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区

第十章宫内人工授精器市场动态

• 市场驱动因素
• 市场课题
• 影响分析

第十一章宫内人工授精器市场机会

第十二章宫内人工授精器市场趋势

第十三章供需分析

• 需求方分析
• 供给面分析

第14章价值链分析

第15章比赛场景

• 竞争状况
  • 波特五力分析

第十六章公司简介

• CooperSurgical Fertility Company
• Cook Group Incorporated
• Vitrolife Sweden AB
• Kitazato Corporation
• FUJIFILM Irvine Scientific
• MEDGYN PRODUCTS, INC.
• Rocket Medical plc.
• Thomas Medical
• Femasys Inc.
• Allwin Medical Devices

第十七章免责声明

Intrauterine insemination (IUI) is a fertility treatment where sperm is directly inserted into a woman's uterus to facilitate fertilization. It's often used when there are issues with sperm motility or when the cause of infertility is unexplained. It's a less invasive and less expensive option compared to in vitro fertilization (IVF). Intrauterine insemination (IUI) devices are specialized tools used by healthcare providers to perform the procedure. These devices are designed to facilitate the placement of sperm directly into the uterus, optimizing the chances of fertilization during the IUI procedure. A rising number of clinical trials and technological advancements are leading to the market's growth. Several other factors, such as rising research & development activities, rising healthcare expenditure, rising regulatory support, and a surge in government collaborations & partnerships are driving the intrauterine insemination devices market globally.

The Intrauterine Insemination Devices Market is expected to grow at a steady rate of around 3.7% owing to the growing prevalence of infertility globally. For instance, according to the World Health Organization, globally one in six people experience infertility in their lifetime. Several factors, including a rising number of clinical trials to find effective treatment, and rising investments in healthcare departments are driving the market's growth during the forecast period. Apart from this, the accelerated launch of intrauterine insemination devices has resulted in higher demand for effective treatment procedures which are also driving this market of intrauterine insemination devices at a steady rate.

Based on the product type, the market is bifurcated into intrauterine insemination catheters and intrauterine insemination sperm wash. The intrauterine insemination sperm wash segment dominated the market in the year 2022 owing to the rising cases of infertility. Intrauterine insemination sperm wash is a process used to prepare sperm for insertion into the uterus during the IUI procedure. It involves separating healthy, motile sperm from the semen sample and removing potentially harmful substances such as prostaglandins, bacteria, and dead sperm. Thus, among the product types, the intrauterine insemination sperm wash segment held a significant market share in 2022.

Based on the end user, the market is categorized into hospitals, IVF clinics, and others. The clinic segment is expected to hold a significant share of the market in the forecast period owing to the rising patient load in hospitals. The clinics segment plays a vital role in the intrauterine insemination (IUI) device market, as clinics are the primary providers of IUI services. This segment encompasses fertility clinics, reproductive health centers, and hospitals offering assisted reproductive technology (ART) services. Key factors influencing this segment include technological advancements in IUI devices, increasing awareness about fertility treatments, and rising demand for alternative conception methods. Additionally, factors such as regulatory policies, reimbursement scenarios, and patient preferences also impact the dynamics of the clinic segment within the IUI device market. Thus, the clinics category will witness a higher CAGR amongst end users during the forecast period.

For a better understanding, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is dominating the market in the current scenario of 2022 due to the surge in cases of infertility, rising healthcare expenditure, and rising initiatives and investments in introducing innovative advancements. For instance, in December 2023, U.S.-based Mosie Baby got FDA clearance for its at-home artificial insemination kit. Government organizations are initiating infertility awareness programs for the sake of the growing cases in the region. Thus, amongst regions, North America held a significant share of the market in 2022.

Some of the major players operating in the market include CooperSurgical Fertility Company; Cook Group Incorporated; Vitrolife Sweden AB; Kitazato Corporation; FUJIFILM Irvine Scientific; MEDGYN PRODUCTS, INC.; Rocket Medical plc.; Thomas Medical; Femasys Inc.; Allwin Medical Devices.

TABLE OF CONTENTS

1.MARKET INTRODUCTION

• 1.1.Market Definitions
• 1.2.Main Objective
• 1.3.Stakeholders
• 1.4.Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1.Research Process of the Intrauterine Insemination Devices Market
• 2.2.Research Methodology of the Intrauterine Insemination Devices Market
• 2.3.Respondent Profile

3.MARKET SYNOPSIS

4.EXECUTIVE SUMMARY

5.IMPACT OF COVID-19 ON THE INTRAUTERINE INSEMINATION DEVICES MARKET

6.INTRAUTERINE INSEMINATION DEVICES MARKET REVENUE (USD BN), 2020-2030F

7.MARKET INSIGHTS BY PRODUCT TYPE

• 7.1.Intrauterine Insemination Catheters
  • 7.1.1.Curved
  • 7.1.2.Flexible
  • 7.1.3.Straight
• 7.2.Intrauterine Insemination Sperm Wash

8.MARKET INSIGHTS BY END USER

• 8.1.Hospitals
• 8.2.Clinics
• 8.3.Others

9.MARKET INSIGHTS BY REGION

• 9.1.North America
  • 9.1.1.U.S.
  • 9.1.2.Canada
  • 9.1.3.Rest of North America
• 9.2.Europe
  • 9.2.1.Germany
  • 9.2.2.U.K.
  • 9.2.3.France
  • 9.2.4.Italy
  • 9.2.5.Spain
  • 9.2.6.Rest of Europe
• 9.3.Asia-Pacific
  • 9.3.1.China
  • 9.3.2.Japan
  • 9.3.3.India
  • 9.3.4.Rest of Asia-Pacific
• 9.4.Rest of World

10.INTRAUTERINE INSEMINATION DEVICES MARKET DYNAMICS

• 10.1.Market Drivers
• 10.2.Market Challenges
• 10.3.Impact Analysis

11.INTRAUTERINE INSEMINATION DEVICES MARKET OPPORTUNITIES

12.INTRAUTERINE INSEMINATION DEVICES MARKET TRENDS

13.DEMAND AND SUPPLY-SIDE ANALYSIS

• 13.1.Demand Side Analysis
• 13.2.Supply Side Analysis

14.VALUE CHAIN ANALYSIS

15.COMPETITIVE SCENARIO

• 15.1.Competitive Landscape
  • 15.1.1.Porters Fiver Forces Analysis

16.COMPANY PROFILED

• 16.1.CooperSurgical Fertility Company
• 16.2.Cook Group Incorporated
• 16.3.Vitrolife Sweden AB
• 16.4.Kitazato Corporation
• 16.5.FUJIFILM Irvine Scientific
• 16.6.MEDGYN PRODUCTS, INC.
• 16.7.Rocket Medical plc.
• 16.8.Thomas Medical
• 16.9.Femasys Inc.
• 16.10.Allwin Medical Devices

17.DISCLAIMER